NO20000066L - 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse - Google Patents

6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse

Info

Publication number
NO20000066L
NO20000066L NO20000066A NO20000066A NO20000066L NO 20000066 L NO20000066 L NO 20000066L NO 20000066 A NO20000066 A NO 20000066A NO 20000066 A NO20000066 A NO 20000066A NO 20000066 L NO20000066 L NO 20000066L
Authority
NO
Norway
Prior art keywords
ylpyrindine
pyrrolidin
derivatives
preparation
pharmaceutical use
Prior art date
Application number
NO20000066A
Other languages
English (en)
Other versions
NO20000066D0 (no
Inventor
Alistair Lochead
Samir Jegham
Frederic Galli
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20000066D0 publication Critical patent/NO20000066D0/no
Publication of NO20000066L publication Critical patent/NO20000066L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen vedrører en forbindelse med generell formel (I) hvor Ri representerer et hydrogenatom, en (C1-C4) -alkylgruppe eller en f enyl (C^-C^) -alkylgruppe, som eventuelt er substituert, R2 representerer et hydrogenatom eller en (C1-C4) -alkylgruppe, og R 09 Rs representerer hver et hydrogenatom eller halogenatom, eller en trif luormetylgruppe, cyanogruppe, hydroksylgruppe, "(C^-Cg) -alkylgruppe eller (C^-Cg) - alkoksygruppe . Oppfinnelsen har terapeutisk anvendelse.
NO20000066A 1997-07-09 2000-01-06 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse NO20000066L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9708706A FR2765874B1 (fr) 1997-07-09 1997-07-09 Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
PCT/FR1998/001446 WO1999002517A1 (fr) 1997-07-09 1998-07-07 Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO20000066D0 NO20000066D0 (no) 2000-01-06
NO20000066L true NO20000066L (no) 2000-03-09

Family

ID=9509040

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000066A NO20000066L (no) 1997-07-09 2000-01-06 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse

Country Status (21)

Country Link
US (1) US6184229B1 (no)
EP (1) EP1000056A1 (no)
JP (1) JP2002508004A (no)
KR (1) KR20010021617A (no)
CN (1) CN1262680A (no)
AR (1) AR013192A1 (no)
AU (1) AU8544498A (no)
BG (1) BG104037A (no)
BR (1) BR9811672A (no)
CA (1) CA2295666A1 (no)
CO (1) CO4890850A1 (no)
EE (1) EE200000018A (no)
FR (1) FR2765874B1 (no)
HU (1) HUP0003856A2 (no)
IL (1) IL133536A0 (no)
NO (1) NO20000066L (no)
PL (1) PL338123A1 (no)
SK (1) SK212000A3 (no)
TR (1) TR200000057T2 (no)
WO (1) WO1999002517A1 (no)
ZA (1) ZA986047B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005126340A (ja) * 2003-10-22 2005-05-19 Kureha Chem Ind Co Ltd 置換ピリドン類の製造法、その原料化合物及びその製造方法
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
CN103977003A (zh) 2007-04-02 2014-08-13 帕金森氏病研究院 用于降低治疗的副作用的方法和组合物
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227391A (en) * 1992-04-10 1993-07-13 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232933A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
ZA986047B (en) 1999-02-01
SK212000A3 (en) 2000-06-12
IL133536A0 (en) 2001-04-30
EE200000018A (et) 2000-08-15
US6184229B1 (en) 2001-02-06
CA2295666A1 (en) 1999-01-21
FR2765874B1 (fr) 1999-08-13
HUP0003856A2 (hu) 2001-10-28
JP2002508004A (ja) 2002-03-12
WO1999002517A1 (fr) 1999-01-21
FR2765874A1 (fr) 1999-01-15
NO20000066D0 (no) 2000-01-06
CO4890850A1 (es) 2000-02-28
TR200000057T2 (tr) 2000-08-21
AR013192A1 (es) 2000-12-13
AU8544498A (en) 1999-02-08
BR9811672A (pt) 2000-09-19
PL338123A1 (en) 2000-09-25
BG104037A (en) 2001-04-30
CN1262680A (zh) 2000-08-09
EP1000056A1 (fr) 2000-05-17
KR20010021617A (ko) 2001-03-15

Similar Documents

Publication Publication Date Title
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
DK1257553T3 (da) Pyrrolopyrimidinonderivater, fremgangsmåder til fremstilling og anvendelse
DK0595851T3 (da) Fremgangsmåde til fremstilling af sertralin-mellemprodukter
DK0871606T3 (da) Nye forbindelser og deres præparat med anti-inflammatorisk og anti-thrombotisk aktivitet
DK1131315T3 (da) Polyhydroxylerede heterocykliske derivater som antikoagulanter
BR9610385A (pt) Novas 4-(oxalcoxifenil)-3-óxi-piperidinas para tratamento de insuficiência cardiáca e renal
ES2077806T3 (es) Derivados de isoxazol, procedimiento para su preparacion y sus aplicaciones herbicidas.
ATE356624T1 (de) Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
NO20045331L (no) Piperazinylacylpiperidinderivater, deres fremstilling og terapeutisk anvendelse derav
DE69231445D1 (de) Triazole enthaltende antifungizide mittel
NO20000066L (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse
DK1222159T3 (da) Mellemprodukter til fremstilling af et benzofuran- eller benzothiophenderivat, som er nitreret i position 5, og anvendelse heraf
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
ES2001106A6 (es) Procedimiento para la obtencion de 1-aril-pirazoles
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
ID24846A (id) Turunan-turunan bifenilamidina
ATE15890T1 (de) Ein fungizides indanylbenzamid.
ATE71619T1 (de) Pyridazinon-derivate.
DK123786D0 (da) 4-(3-carboxy-3-diazo-2-oxopropyl)-azetidin-2-oner, deres fremstilling og anvendelse som carbapenemantibiotikummellemprodukter
NO961404L (no) 4-indolylpiperazinyl-derivater
DK546286D0 (da) Piperidinderivater eller salte deraf og deres anvendelse som farmaceutika
ATE191465T1 (de) Carbamoylcarbonsäureamide
DE69510510D1 (de) N-benzoylmethylsubstituierte paroxetinderivate
SE8605458D0 (sv) 4-hydroxycoumarin derivatives
BR0206206A (pt) Derivados de etoposide e análogos, e composições farmacêuticas contendo os mesmos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application